Lawson covers the Healthcare sector, focusing on stocks such as Relay Therapeutics, Arcus Biosciences, and Syndax Pharmaceuticals. In addition to Barclays, Prelude Therapeutics also received a Sell ...

WILMINGTON, DE — Prelude Therapeutics Incorporated (Nasdaq: PRLD), a precision oncology company, has shared its third-quarter ...

Analyst Reni Benjamin from JMP Securities reiterated a Buy rating on Prelude Therapeutics (PRLD – Research Report) and keeping the price ...

UBS Posts Upbeat Earnings, Joins Victoria's Secret, Performance Food Group, Kellanova And Other Big Stocks Moving Higher On Wednesday Avi Kapoor Best Buy To Rally More Than 21%? Here Are 10 Top ...

Prelude has shown strategic foresight by initiating collaborations with established pharmaceutical companies. Notably, the company plans to begin a combination trial of PRT3789 with Merck's ...